Cargando…
Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study
AIMS: The FLXibility Post-Approval Study collected data on unselected patients implanted with a WATCHMAN FLX in a commercial clinical setting. METHODS AND RESULTS: Patients were implanted with a WATCHMAN FLX per local standard of care, with a subsequent first follow-up visit from 45 to 120 days post...
Autores principales: | Betts, Tim R, Grygier, Marek, Nielsen Kudsk, Jens Erik, Schmitz, Thomas, Sandri, Marcus, Casu, Gavino, Bergmann, Martin, Hildick-Smith, David, Christen, Thomas, Allocco, Dominic J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062328/ https://www.ncbi.nlm.nih.gov/pubmed/36734247 http://dx.doi.org/10.1093/europace/euac270 |
Ejemplares similares
-
Two‐Year Outcomes With a Next‐Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial
por: Doshi, Shephal K., et al.
Publicado: (2023) -
Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know
por: Merella, Pierluigi, et al.
Publicado: (2023) -
Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry
por: Boersma, Lucas V.A., et al.
Publicado: (2016) -
Delayed embolization of next-generation left atrial appendage closure device in an asymptomatic patient
por: Bhagat, Aditi, et al.
Publicado: (2023) -
Left atrial appendage occlusion in COVID-19 times
por: Freixa, Xavier, et al.
Publicado: (2020)